Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Fusco

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
European Journal of Radiology|December 31, 2016
Erratum to "Biparametric 3t magnetic resonance imaging for prostatic cancer detection in a biopsy-naïve patient population: A further improvement of PI-RADS v2? [Eur. J. Radiol. 85 (12) (2016) 2269-2274]"Arnaldo Stanzione, Massimo Imbriaco, Sirio Cocozza, et al.
Annali Italiani Di Chirurgia|July 27, 2021
Impact of SARS-Cov-2 pandemic on Emergency General Surgery. A single-center observational studyAlfonso Amendola, Giuseppe Palomba, Maria Gaudiello, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxationRoberta d'Emmanuele di Villa Bianca, Raffaella Sorrentino, Pasquale Maffia, et al.
Current Urology|October 8, 2025
Patients with frailty, benign prostatic hyperplasia and indwelling bladder catheter: What are the 1-year outcomes after Rezūm therapy?Raffaele Balsamo, Simone Tammaro, Ferdinando Fusco, et al.
Plos One|February 10, 2012
Endogenous urotensin II selectively modulates erectile function through eNOSRoberta d'Emmanuele di Villa Bianca, Emma Mitidieri, Ferdinando Fusco, et al.
Minerva Urology and Nephrology|February 7, 2020
Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatmentMassimiliano Creta, Claudia Collà Ruvolo, Nicola Longo, et al.
World Journal of Urology|December 11, 2014
Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?Ferdinando Fusco, Davide Arcaniolo, Massimiliano Creta, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2005
Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosumRoberta d'Emmanuele di Villa Bianca, Raffaella Sorrentino, Rosalinda Sorrentino, et al.
Minerva Urology and Nephrology|July 26, 2021
Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complicationsCeleste Manfredi, Davide Arcaniolo, Pietro Spatafora, et al.
Scientific Reports|August 12, 2016
Urothelium muscarinic activation phosphorylates CBS(Ser227) via cGMP/PKG pathway causing human bladder relaxation through H2S productionRoberta d'Emmanuele di Villa Bianca, Emma Mitidieri, Ferdinando Fusco, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
European Journal of Radiology|December 31, 2016
Erratum to "Biparametric 3t magnetic resonance imaging for prostatic cancer detection in a biopsy-naïve patient population: A further improvement of PI-RADS v2? [Eur. J. Radiol. 85 (12) (2016) 2269-2274]"Arnaldo Stanzione, Massimo Imbriaco, Sirio Cocozza, et al.
Annali Italiani Di Chirurgia|July 27, 2021
Impact of SARS-Cov-2 pandemic on Emergency General Surgery. A single-center observational studyAlfonso Amendola, Giuseppe Palomba, Maria Gaudiello, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxationRoberta d'Emmanuele di Villa Bianca, Raffaella Sorrentino, Pasquale Maffia, et al.
Current Urology|October 8, 2025
Patients with frailty, benign prostatic hyperplasia and indwelling bladder catheter: What are the 1-year outcomes after Rezūm therapy?Raffaele Balsamo, Simone Tammaro, Ferdinando Fusco, et al.
Plos One|February 10, 2012
Endogenous urotensin II selectively modulates erectile function through eNOSRoberta d'Emmanuele di Villa Bianca, Emma Mitidieri, Ferdinando Fusco, et al.
Minerva Urology and Nephrology|February 7, 2020
Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatmentMassimiliano Creta, Claudia Collà Ruvolo, Nicola Longo, et al.
World Journal of Urology|December 11, 2014
Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?Ferdinando Fusco, Davide Arcaniolo, Massimiliano Creta, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2005
Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosumRoberta d'Emmanuele di Villa Bianca, Raffaella Sorrentino, Rosalinda Sorrentino, et al.
Minerva Urology and Nephrology|July 26, 2021
Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complicationsCeleste Manfredi, Davide Arcaniolo, Pietro Spatafora, et al.
Scientific Reports|August 12, 2016
Urothelium muscarinic activation phosphorylates CBS(Ser227) via cGMP/PKG pathway causing human bladder relaxation through H2S productionRoberta d'Emmanuele di Villa Bianca, Emma Mitidieri, Ferdinando Fusco, et al.
Pageof 17